carmustine and dronabinol

carmustine has been researched along with dronabinol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G1
Boehm, P; Divi, MK; Duntsch, C; Jones, T; Krishnamurthy, M; Moore, BM; Sills, A; Wood, G; Zhou, Q1
García-Taboada, E; Guzmán, M; Hernández-Tiedra, S; López-Valero, I; Lorente, M; Salazar-Roa, M; Sepúlveda, JM; Torres, S; Velasco, G1

Trials

1 trial(s) available for carmustine and dronabinol

ArticleYear
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Clinical Protocols; Cyclophosphamide; Diphenhydramine; Double-Blind Method; Dronabinol; Female; Humans; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Placebos; Prochlorperazine; Transplantation, Autologous; Vomiting

1995

Other Studies

5 other study(ies) available for carmustine and dronabinol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma.
    Journal of neuro-oncology, 2006, Volume: 77, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cannabinoids; Carmustine; Cell Line, Tumor; Dronabinol; Drug Administration Schedule; Glioma; Humans; Inhibitory Concentration 50; Mice; Mice, SCID; Organ Culture Techniques

2006
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
    Biochemical pharmacology, 2018, Volume: 157

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Carmustine; Cell Line, Tumor; Dronabinol; Glioma; Heterografts; Humans; Male; Mice, Nude; Temozolomide

2018